ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Prime Medicine Inc

Prime Medicine Inc (PRME)

2.595
0.045
(1.76%)
Closed February 14 4:00PM
2.65
0.055
(2.12%)
After Hours: 7:08PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.000.000.000.000.000.00 %00-
5.000.000.000.000.000.000.00 %00-

Professional-Grade Tools, for Individual Investors.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.300.350.300.3250.000.00 %012-
5.000.903.300.002.100.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSLKBolt Projects Holdings Inc
$ 1.228
(302.62%)
273.1M
MBRXMoleculin Biotech Inc
$ 1.27
(202.38%)
107.27M
CSAICloudastructure Inc
$ 38.0312
(115.72%)
3.42M
PEVPhoenix Motor Inc
$ 0.5101
(102.34%)
280M
AMODAlpha Modus Holdings Inc
$ 3.605
(95.92%)
125.94M
RFACRF Acquisition Corporation
$ 2.63
(-69.42%)
685.37k
RFACURF Acquisition Corporation
$ 3.17
(-56.93%)
36.61k
HTLMHomesToLife Ltd
$ 4.00
(-56.90%)
1.24M
DGLYDigital Ally Inc
$ 0.0879
(-43.29%)
117.51M
TOIIWOncology Institute Inc
$ 0.024
(-39.09%)
5.96k
MGOLMGO Global Inc
$ 0.835
(82.99%)
739.4M
PEVPhoenix Motor Inc
$ 0.5101
(102.34%)
280M
BSLKBolt Projects Holdings Inc
$ 1.228
(302.62%)
273.1M
INTCIntel Corporation
$ 24.13
(7.34%)
248.66M
NVDANVIDIA Corporation
$ 135.29
(3.16%)
197.44M

PRME Discussion

View Posts
Monksdream Monksdream 2 months ago
PRME, under $

👍️0
PonkenPlonken PonkenPlonken 2 months ago
Super super undervalued..
Recent PSTX - Roche deal should have made this run? Atleast given it also recently partnered with BMS... makes zero sense.
Is a clear validation CRISPR genome editing is hot in cancer cell therapy.
Waiting for a sign....
👍️0
Monksdream Monksdream 4 months ago
PRME under $5
👍️0
Monksdream Monksdream 4 months ago
PRME new 52 week low
👍️0
Invest-in-America Invest-in-America 4 months ago
PRME: Glad I grabbed a chunk of THIS ONE!!!!
👍️0
PonkenPlonken PonkenPlonken 4 months ago
"Under the terms of the agreement, Prime Medicine will receive a $55 million upfront payment and a $55 million equity investment from Bristol Myers Squibb. Prime Medicine is also eligible to receive more than $3.5 billion in milestones,..."

"On the Effective Date, the Company entered into the Purchase Agreement with BMS, pursuant to which the Company agreed to issue and sell, and BMS agreed to purchase, in an unregistered offering (the “Offering”), 11,006,163 shares [...] for an aggregate purchase price of $55.0 million..."
👍️0
Monksdream Monksdream 5 months ago
PRME new 52=week low
👍️0
wiwineguy wiwineguy 5 months ago
K. I'm in!
👍️0
Monksdream Monksdream 5 months ago
DAKT
👍️0
wiwineguy wiwineguy 5 months ago
You are amazing Monk. Any recommendations
👍️0
Monksdream Monksdream 5 months ago
PRME under $5
👍️0
Monksdream Monksdream 6 months ago
PRME new 52 week low
👍️0
Monksdream Monksdream 7 months ago
PRME under $6
👍️0
Monksdream Monksdream 7 months ago
PRME under $10:
👍️0
Monksdream Monksdream 8 months ago
Great post
Friday Cathie Wood bought more shares for her flagship Ark Fund (ARKK)
I think she has been buying on the decline
She isn’t particularly interested in how well or how lousy the management controls costs it’s the potential she believes exists
There are about a dozen, if not more, listed gene editing companies
Not all will make it before they run out of money and have to raise more operating capital
Notice the $2 to $4 bounces on the way to lower lows
👍️0
Monksdream Monksdream 9 months ago
PRME under $10
👍️0
jondoeuk jondoeuk 9 months ago
PRME vs Tome vs Tessera vs NTLA vs CRSP vs...!

They fact this article needs to be written could mean a legal battle is coming https://www.nature.com/articles/s41587-024-02208-0
👍️0
NY1972 NY1972 10 months ago
This $500M company burns $200M a year. These PhDs have been spoiled by Wall St. when money was cheap. Who wants to be their sugar daddy?
👍️0
jondoeuk jondoeuk 10 months ago
I'm sure in the (near) future they will (functionally) cure (rare) diseases, but not before they dilute a whole bunch more.
👍️0
jondoeuk jondoeuk 12 months ago
The CEO has been contently telling investors how easy it would be to bring in funding through partnerships and how difficult capital markets are. Yet they did a secondary. He needs to go. Also, I don't think their IP is gatekeeping others.
👍️0

Your Recent History

Delayed Upgrade Clock